Procalcitonin in patients undergoing cardiopulmonary bypass in open heart surgery - First results of the procalcitonin in heart surgery study (ProHearts)

Intensive Care Medicine, Supplement

Volumn 26, Issue 2, 2000, Pages

  Loebe, M ^a   Locziewski, S ^a   Brunkhorst, F M ^b   Harke, C ^a   Hetzer, R ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass graft; Endotoxin; Hypotension; Procalcitonin; Prognosis; Systemic inflammatory response syndrome (SIRS); Thoracic aortic surgery; Valve surgery

Indexed keywords

ENDOTOXIN; PROCALCITONIN;

ADOLESCENT; ADULT; AGED; AORTA SURGERY; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; HEART VALVE SURGERY; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; OPEN HEART SURGERY; POSTOPERATIVE PERIOD; PROGNOSIS; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0034070189     PISSN: 09351701     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02900737     Document Type: Article

References (28)

1. 1. Hammerschmidt DE, Stroncek DF, Bowers TK (1981) Complement activation and neutropenia during cardiopulmonary bypass. J Thorac Cardiovasc Surg 81: 370-377
2. 2. Baier RE, Dutton RC (1969) Initial events in interactions of blood with foreign surfaces. J Biomed Mater Res 3: 191-206
3. 3. Menache P, Haydar S, Peynet J (1994) One potential mechanism of vasodilatation after warm heart surgery: the temperature dependent release of cytokines. J Thorac Cardiovasc Surg 107: 293-299
4. 4. Butler J, Chong GL, Baigrie RJ (1992) Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenator. Ann Thorac Surg 53: 833-838
5. 5. Schirmer WJ, Schirmer JM, Naff GB, Fry DE (1988) Systemic complement activation produces hemodynamic changes characteristic of sepsis. Arch Surg 123: 316-321
6. 6. Loebe M, Hennig E, Moller J, Spiegelsberger S, Weng Y, Hetzer R (1997) Long-term mechanical circulatory support as a bridge to transplantation, for recovery from cardiomyopathy, and for permanent replacement. Europ J Cardio Thorac Surg 11[Suppl]: 8-24
7. 7. Argenziano M, Choudhri AF, Salehizadeh B, et al (1997) A novel approach to the treatment of vasodilatory shock after cardiac transplantation. Circulation 96: 371 (abstract)
8. 8. Andresen LW, Baek L, Degn H, et al (1987) Presence of circulating endotoxins during cardiac operations. J Thorac Cardiovasc Surg 93: 115-119
9. 9. Rocke DA (1987) Endotoxinemia associated with cardiopulmonary bypass. J Thorac Cardiovasc Surg 93: 882-837
10. 10. Assicot M, Gendrel G, Carsin H, Raymond J, Guilbaud J, Bohoun C (1993) High serum procalcitonin concentration in patients with sepsis and infection. Lancet 341: 515-518
11. 11. DeWerra I, Jaccard C, Corradin SB et al. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 25: 607-13
12. 12. Ugarte H, Silver E, Mercan D, De Mendonca A, Vincent J-L (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27: 498-504
13. 13. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M et al. (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79: 1605-8
14. 14. Reith HB, Mittelkötter U, Debus ES, Küssner C, Thiede A (1998) Procalcitonin in early detection of postoperative complications. Dig Surg 15: 260-65
15. 16. Oberhoffer M, Bögel D, Meier-Hellmann A, Vogelsang H, Reinhart K (1996) ACCP/SCCM Consensus Conference definitions correlate better with procalcitonin than tumor-necrosis-factor and Interleukin-6. Intensive Care Med 22: Suppl 1:S15 (abstract)
16. 17. Oberhoffer M, Vogelsang H, Russwurm S, Hartung T, Reinhart K (1999) Outcome prediction by traditional and new markers of inflammation in patients with sepsis. Clin Chem Lab Med 37(3): 363-68
17. 18. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K (1997) Procalcitonin - a new indicator for the systemic response to infection. Infection 25 (6): 329-34
18. 19. Nijsten MWN, Schraffordt Koops H, Bijzet J, van Ginkel RJ, Zwaveling JH (1998) Pro-Calcitonin levels show a very fast rise after isolated limb TNF-perfusion in oncologic patients. Intensive Care Med 24: S139 (abstract)
19. 20. Eberhardt OK, Langefeld I, Kuse ER et al. (1998) Procalcitonin in the early phase after renal transplantation - will it add to diagnostic accuracy? Clin Transplant 12: 206-211
20. 21. Kilger E, Pichler B, Goetz AE et al. (1998) Procalcitonin as a marker of systemic inflammation after conventional or minimally invasive coronary artery bypass grafting. Thorac Cardiovasc Surg 46: 130-133
21. 22. Meisner M, Tschaikowsky K, Schmidt J, Schüttler J (1996) Procalcitonin (PCT) - indications for a new diagnostic parameter of severe bacterial infection and sepsis in transplantation, immunosuppression and cardiac assist devices. Cardiovasc Engineer 1: 67-76
22. 23. Oudemans-van Straaten HM (1996) Increased oxygen consumption after cardiac surgery is associated with the inflammatory response to endotoxinemia. Intensive Care Med 22: 294-300
23. 24. Anker SD, Egerer K, Volk H-D, Kox WJ, Poole-Wilson PA, Coats AJS (1997) Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol 79: 1426-30
24. 25. Niebauer J, Volk H-D, Kemp P, et al. (1999) Endotoxin and immunactivation in chronic heart failure: a prospective cohort study. Lancet 353: 1838-42
25. 26. Brunkhorst F, Niebauer J, Anker SD (1999) Endotoxins in chronic heart failure. Lancet 354: 599-600
26. 27. Cremer J, Martin M, Redl H, et al. (1996) Systemic inflammatory response syndrome after cardiac operations. Ann Thorac Surg 61: 1714-20
27. 28. Wang X, Jones SB, Zhengzheng Z, Han C, Fiscus RR (1992) Calcitonin Gene-related peptide (CGRP) and neuropeptide Y (NPY) levels are elevated in plasma and decreased in vena cava during endotoxin shock in rats. Circulatory Shock 36: 21-30
28. 29. Kristof AS, Magder S (1999) Low systemic vascular resistance state in patients undergoing cardiopulmonary bypass. Crit Care Med 27: 1121-1127